Cannabis Law Report

JANUARY 4, 2022

Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse, has named Simon Allen as Chief Executive Officer and a member of the company’s Board of Directors, effective February 1 st , 2022. Anebulo Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Cannabinoids 52

CannaMD

AUGUST 26, 2020

A new review published by scientific journal, Pharmacology Biochemistry and Behavior , has found that marijuana cannabinoid, CBD, is a “promising” therapy for treating cocaine dependence. Exploring alternative therapies, researchers turned their attention to marijuana cannabinoid, cannabidiol – more commonly referred to as CBD.

Therapy 98

Therapy CBD Research and Development Treatment 98

Freedom Leaf

JULY 20, 2017

Specifically, a 2016 study involving a significantly larger cohort of NHANES participants reported that “current marijuana use is associated with lower odds of metabolic syndrome.” “Longitudinal research is required to define the true relationship between marijuana use and metabolic syndrome.”

Blood Pressure 43

Blood Pressure Research and Development Clinical Trials History 43

Cannabis Law Report

SEPTEMBER 1, 2019

By early 2016, Australia’s federal parliament passed a bill that laid the groundwork for cannabis to be legally cultivated and manufactured for medicinal and scientific purposes here. In late 2016, Faenza was working with a team to identify potential Australian sites and scan the international market for the best production methods.

Clinical Trials 53

Clinical Trials Research and Development Medicine Cultivation 53

Cannabis Law Report

APRIL 8, 2019

Through the Narcotic Drugs Amendment Act 2016 (Cth) and its amendments to the Narcotic Drugs Act 1967 (Cth) ( NDA ), the Australian Government commenced the legalisation of medicinal cannabis products in Australia under federal law in 2016. Josh Hunt – Partner. Callum Twigger – Lawyer. Chapter 2 of the NDA.

Medicine 71

Medicine Research and Development Business Cannabis 71

Cannabis Law Report

MARCH 21, 2019

All cannabis plants contain cannabinoids, which are a group of similar compounds. The industrial hemp plant happens to contain large quantities of special cannabinoids known as cannabidiol or CBD for short. In 2016, Tennessee legalized the use of CBD containing no more than 0.9% One variation of cannabis is called hemp.

State Laws 55

State Laws Law CBD Legalization 55

Cannabis Law Report

JANUARY 24, 2022

North America Legal Cannabis Number of clinical trials. Qualitative analysis on synthetic cannabinoids and cannabis in North America. Qualitative analysis on synthetic cannabinoids and cannabis in North America. Hemp Market Estimates and Forecasts, 2016-2028 (USD Million). Market Segmentation. Market Dynamics.

Legalization 40

Legalization Supply Chain Chronic Pain Recreational 40

The Cannigma

AUGUST 26, 2021

The country legalized medical cannabis in 2016, but patients in the country have long criticized the program as too restrictive, and access to cannabis-based medicines remains behind that of many other legal cannabis jurisdictions. percent) remains far higher than the world average (3.9 Costs of medical marijuana.

Legalization 52

Legalization Access Medicine Clinical Trials 52

Weedistry

MARCH 11, 2019

Founded in 2016 by Robert Rosenheck, who has a branding background, and his wife, Cindy Capobianco, who has led public relations for Banana Republic and marketing for Gap, it is a leader in a movement to make marijuana more attractive to a mainstream audience. “The It really does work for pain management.”. von Pfetten said. Idriss said. “It

Oil 40

Oil CBD Wellness and Beauty Clinical Trials 40

Cannabis Law Report

JANUARY 11, 2019

Furthermore, by redefining hemp to include its “extracts, cannabinoids and derivatives,” Congress explicitly removed popular hemp products – such as hemp-derived CBD — from the purview of the CSA. It is now deemed an agricultural commodity, no longer able to be classified as a controlled substance, like marijuana.

Hemp 49

Hemp CBD Law Seed-To-Sale 49

Cannabis Law Report

SEPTEMBER 3, 2019

(TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, is pleased to announce that its subsidiary MediPharm Labs Australia Pty. Australian Leadership Appointments.

Pharmaceutical 45

Pharmaceutical Extraction Research and Development Supply Chain 45

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. Legalisation occurred in Australia in 2016. The recreational use of cannabis is well known and attributed to its power as a psychotropic plant, specifically due to the cannabinoid tetrahydrocannabinol (THC).

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JUNE 11, 2019

A modest award for the cost of Cesamet/Nabilone, the synthetic cannabinoid, was awarded in this case. A pain management specialist recommended a trial of Nabilone, the synthetic cannabinoid, or of medical marijuana. I decline to award a sum of money to permit the plaintiff to experiment with cannabinoids; … 23.

Chronic Pain 45

Chronic Pain Cannabis History Treatment 45

Cannabis Law Report

JUNE 10, 2021

Washington, DC: AAA Foundation for Traffic Safety; 2016. GfK KnowledgePanel 2016. Cannabis Cannabinoid Res. 9-tetrahydrocannabinol on driving performance: a randomized clinical trial. Arnold LS, Tefft BC. Driving under the influence of alcohol and marijuana: beliefs and behaviors, United States, 2013–2015.

Policy 45

Policy Safety Marijuana Data 45

Project CBD

OCTOBER 26, 2023

There is a growing body of anecdotal and scientific evidence that the “major cannabinoids” tetrahydrocannabinol (THC) and cannabidiol (CBD), certain “minor cannabinoids” (some without a name), and other cannabis compounds have antineoplastic action against cancer cells. THC binds to two types of cannabinoid receptors, CB1 and CB2.

Research and Development 347

Research and Development Cannabinoids Terpenes Pharmaceutical 347

FloridaMarijuana.net

AUGUST 13, 2018

The Journal of Affective Disorders published a 2016 Swedish study which surveyed 8598 Swedish men and women. Published in 2016, “ Cannabis and Cannabinoid Research,” written by Michelle Sexton, Carrie Cuttler, John S. The researchers concluded that: Cannabis users had no increased risk of depression and anxiety at follow-up.

Marijuana 145

Marijuana Patients Clinical Trials Conditions 145

The Cannigma

MAY 13, 2022

There have been a number of preclinical and clinical trials studying cannabis’ effects on pain. When shopping for a strain for chronic pain, look for one that matches the cannabinoid and terpene profile, not one that matches the strain name exactly. And this is an area of ample scientific research. So what should you use?

Terpenes 111

Terpenes Strains Chronic Pain Clinical Trials 111

Cannabis Law Report

JUNE 4, 2021

We support the Hemp Roundtable’s statements on psychoactive hemp and that it should be regulated separately from hemp, CBD, CBG and other non-psychoactive or non-intoxicating cannabinoids. Delta 8-THC is a psychoactive cannabinoid, just like Delta 9-THC, and legislators should regulate it as such.

Research and Development 105

Research and Development Seed-To-Sale Cannabinoids THC 105

CannaMD

NOVEMBER 6, 2019

In addition, data from the 2017 National Survey on Drug Use and Health showed a potential inverse relationship between marijuana and opioid use, based on data that reported a drop of opioid misuse from 2016 to 2017 (from 11.8 Those who received the cannabinoid medication Dronabinol had shorter lengths of stay and consumed fewer opioids.

Marijuana 107

Marijuana Patients Clinical Trials Data 107

The Cannigma

JANUARY 13, 2023

The authors noted that while “promising data are emerging on the possible role of ECS in migraine…proper placebo-controlled trials are needed to establish a therapeutic role for cannabinoids.” Chemovars classify cannabis based on the dominant cannabinoid, and there are three main types on the market right now.

Terpenes 132

Terpenes Strains THC Treatment 132

CannaMD

MARCH 8, 2021

Lastly, by imposing an arbitrary potency cap on just one of marijuana’s 100-plus cannabinoids, H.B. In 2016, the pharmaceutical industry spent $9.6 Cesamet, like dronabinol-containing products, is indicated for nausea associated with cancer chemotherapy. All forms of advertising and free speech remain available and intact.

THC 116

THC Research and Development Treatment Patients 116

Cannabis Law Report

OCTOBER 29, 2019

Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.

Safety 45

Safety CBD Clinical Trials Oil 45

The Cannigma

APRIL 8, 2021

Yeah, there are thousands of strains, but those thousands of strains, but those thousands of strains only make let’s say one or two of 60 cannabinoids in abundance. Half of those cannabinoids of plant doesn’t make or three quarters because they’re byproducts. This is by nature of the way we consume cannabinoids.

Medicine 108

Medicine Cannabinoids Cannabis THC 108

Cannabis Law Report

MAY 29, 2022

Clinical Trials and Human Subject Protections. Before the drug approval process even begins, sponsors must initiate clinical investigations by first filing an Investigational New Drug Application (IND) with FDA. FDA’s approval of an IND will also require sufficient evidence that the trial will be safe for human subjects.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

APRIL 10, 2019

MP Philippa Whitford (representing Central Ayrshire ), a doctor, called for more support for clinical trials so that doctors will be more willing to prescribe medical cannabis products: “That is quite scary for doctors, particularly as if it is an unlicensed drug, they have to sign a form to say that they accept personal liability.

Clinical Trials 51

Clinical Trials Epilepsy Medicine Research and Development 51

Cannabis Law Report

JULY 12, 2019

International Cannabinoid Cancer Research Institute (Draft 5). This paper seeks to answer why refined cannabinoids have more side effects than the natural cannabis product, as well as the possible etiology of said adverse reactions. Also discussed are other attempts at affecting the cannabinoid system from a singular standpoint.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Healer

MARCH 26, 2021

THC is the main psychoactive compound in marijuana, while CBD is a non-intoxicating cannabinoid found in the cannabis plant. Seventeen of 19 pre-clinical studies provided “robust” evidence of the opioid-sparing effects of cannabinoids, but one of the nine clinical studies provided “very low-quality” evidence of such, according to the review.

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

Green Relief

MAY 13, 2018

government-held patent pertaining to “cannabinoids as antioxidants and neuroprotectants,” CBD and THC can limit “neurological damage following ischemic insults, such as stroke or trauma.”. As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury.

THC 64

THC CBD Cannabinoids Research and Development 64

Green Relief

MAY 12, 2018

government-held patent pertaining to “cannabinoids as antioxidants and neuroprotectants,” CBD and THC can limit “neurological damage following ischemic insults, such as stroke or trauma.”. As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40

NORML

SEPTEMBER 20, 2019

Essentially, the federal government has monopolized cannabis research, and ElSohly’s product, according to some scientists who’ve seen it, is unsuitable for clinical trials. The testing did confirm that the [batch sent by NIDA] has cannabinoids, some very minute quantities of terpenes in it, and that it was cannabis.

DEA 226

DEA Research and Development Clinical Trials Patients 226

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Rick Doblin, Ph.D, in/rickdoblin/ [link]. in/ingmargorman/ [link]. Zach’s been writing it since May of 2019. Graham Pechenik.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51